These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2144431)

  • 81. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates.
    Cosio FG; Shen XP; Birmingham DJ; Van Aman M; Hebert LA
    J Immunol; 1990 Dec; 145(12):4198-206. PubMed ID: 2147938
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
    Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
    Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages.
    Craig ML; Bankovich AJ; Taylor RP
    Clin Immunol; 2002 Oct; 105(1):36-47. PubMed ID: 12483992
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Release of immune complexes bound to erythrocyte complement receptor (CR1), with particular reference to the role of factor I.
    Jepsen HH; Svehag SE; Jensenius JC; Sim RB
    Scand J Immunol; 1986 Aug; 24(2):205-13. PubMed ID: 2944215
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 87. C3b receptor (CR1) on erythrocytes in various diseases.
    Takemura S; Deguchi M; Ueda M; Yoshida N; Kato H; Yoshikawa T; Sugino S; Kondo M
    Immunol Lett; 1984; 7(6):325-8. PubMed ID: 6233222
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Use of complement receptor 1 (CD35) assay in the diagnosis and prognosis of immune complex mediated glomerulopathies.
    Raju KR; Sivasankar B; Anand V; Luthra K; Tiwari SC; Dinda AK; Das N; Srivastava LM
    Asian Pac J Allergy Immunol; 2001 Mar; 19(1):23-7. PubMed ID: 11495296
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 90. C3b receptor (CR1) on phagocytic cells from SLE patients: analysis of the defect and familial study.
    Mir A; Porteu F; Levy M; Lesavre P; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1988 Sep; 73(3):461-6. PubMed ID: 2974768
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients.
    Teixeira JE; Martinez R; Câmara LM; Barbosa JE
    Mycopathologia; 2001; 152(3):125-33. PubMed ID: 11811640
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood.
    Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG
    Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease.
    de Carvalho Lins CE; Pereira Crott LS; Teixeira JE; Barbosa JE
    Lupus; 2004; 13(7):517-21. PubMed ID: 15352423
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.
    Oudin S; Libyh MT; Goossens D; Dervillez X; Philbert F; Réveil B; Bougy F; Tabary T; Rouger P; Klatzmann D; Cohen JH
    J Immunol; 2000 Feb; 164(3):1505-13. PubMed ID: 10640768
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
    Edberg JC; Wright E; Taylor RP
    J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
    Taylor RP; Ferguson PJ; Martin EN; Cooke J; Greene KL; Grinspun K; Guttman M; Kuhn S
    Clin Immunol Immunopathol; 1997 Jan; 82(1):49-59. PubMed ID: 9000042
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
    Moldenhauer F; Botto M; Walport MJ
    Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Quantitation and antigenic characterization of bound C3 of circulating immune complexes in systemic lupus erythematosus, rheumatoid arthritis, and primary biliary cirrhosis.
    Nilsson B; Bjelle A; Lööf L; Nilsson UR
    J Clin Immunol; 1987 Sep; 7(5):420-6. PubMed ID: 2443529
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Serum complement activation of SLE patients during plasmapheresis.
    Csipö I; Kávai M; Kiss E; Bedö Z; Csongor J; Szegedi G; Philbert F; Cohen JH
    Autoimmunity; 1997; 25(3):139-46. PubMed ID: 9272279
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The binding of immune complexes by the erythrocyte complement receptor 1 (CR1).
    Pascual M; Schifferli JA
    Immunopharmacology; 1992; 24(2):101-6. PubMed ID: 1473961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.